SCHEMBL11990602

SCHEMBL11990602

CCOC(=O)OCC(=O)[C@@]1(OC(=O)OCC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 11/20 0.65
▸ PGR P06401 9/20 0.65
▸ HIF1A Q16665 6/20 0.65
▸ LMNA P02545 4/20 0.65
▸ USP2 O75604 3/20 0.65
▸ CYP3A4 P08684 3/20 0.65
▸ CYP2C9 P11712 2/20 0.65
▸ CYP2D6 P10635 1/20 0.65
▸ NR1I2 O75469 3/20 0.64
▸ CNR1 P21554 3/20 0.64
▸ ABCB11 O95342 2/20 0.60
▸ ABCC3 O15438 1/20 0.60
▸ KDM4E B2RXH2 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ HSD17B10 Q99714 2/20 0.52
▸ TNF P01375 1/20 0.52
▸ IL6 P05231 1/20 0.52
▸ SERPINA6 P08185 1/20 0.52
▸ NR3C2 P08235 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11296376 0.91 NR3C1 (0.63) NR3C1PGRHIF1ALMNAUSP2
SCHEMBL4222312 0.90 NR3C1 (0.64) NR3C1PGRHIF1ALMNAUSP2
SCHEMBL11561586 0.90 NR3C1 (0.60) NR3C1PGRHIF1ALMNAUSP2
SCHEMBL4222316 0.90 NR3C1 (0.63) NR3C1PGRHIF1ALMNAUSP2
SCHEMBL23892577 0.88 NR3C1 (0.73) NR3C1PGRHIF1ALMNAUSP2
SCHEMBL19393185 0.88 NR3C1 (0.73) NR3C1PGRHIF1ALMNAUSP2
SCHEMBL19681910 0.88 NR3C1 (0.73) NR3C1PGRHIF1ALMNAUSP2
SCHEMBL11054207 0.88 NR3C1 (0.73) NR3C1PGRHIF1ALMNAUSP2
SCHEMBL11045196 0.88 NR3C1 (0.73) NR3C1PGRHIF1ALMNAUSP2
SCHEMBL11045199 0.88 NR3C1 (0.73) NR3C1PGRHIF1ALMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200046845-A1 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY CERULEAN PHARMA INC. 2020-02-13 — — US disclosed
US-20120213854-A1 METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS CERULEAN PHARMA INC. 2012-08-23 — — US disclosed
US-20120213854-A1 METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS CERULEAN PHARMA INC. 2012-08-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200046845-A1 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY CDR2, DDOST, GALC NR3C1 598/4885PGR 3603/4885HIF1A 4431/4885
US-20120213854-A1 METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS HLA-DRB1, TSG101, IAPP NR3C1 726/4885PGR 3157/4885HIF1A 2705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback